Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective Registry Clinical Study of the Effectiveness and Safety of ReVive SE Thrombectomy for Acute Ischemic Stroke

NCT03007082 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT03007082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03007082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective Registry Clinical Study of the Effectiveness and Safety of ReVive SE Thrombectomy for Acute Ischemic Stroke
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2016
Completion date
February 28, 2018
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, occlusion, cerebrovascular